Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. ABCA transporter gene expression and poor outcome in epithelial ovarian cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Short telomere length, cancer survival, and cancer risk in 47102 individuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Dexamethasone Dose and Early Postoperative Recovery after Mastectomy: A Double-blind, Randomized Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Indications for adjuvant endocrine treatment of breast cancer have gradually increased over the past several years. We aimed to define subgroups of patients who may or may not benefit from adjuvant endocrine therapy.
OriginalsprogEngelsk
TidsskriftNational Cancer Institute. Journal (Print)
Vol/bind103
Udgave nummer18
Sider (fra-til)1363-72
Antal sider10
ISSN0027-8874
DOI
StatusUdgivet - 2011

ID: 33154149